Logo_AIHTA
  • English
            Menu_button
                              • Team
                                                                          • Eva Malikova
                                                                                          Video
                                                                                          Video: What is HTA?    
                                                                                          • Home
                                                                                          • About us
                                                                                          • Team
                                                                                          • Eva Malikova

                                                                                          PharmDr. Eva Malikova PhD.

                                                                                          Eva-malikova-web

                                                                                          Researcher 
                                                                                          Pharmacy

                                                                                          phone: +43(0)1-2368119-35
                                                                                          E-mail: eva.malikova[at]aihta.at

                                                                                           

                                                                                           


                                                                                          Eva Malikova joined AIHTA in 2024 as a research associate in the field of pharmacy. She completed her master's and PhD studies at the Faculty of Pharmacy, Comenius University in Bratislava, Slovakia, where she started as a post-doc in 2016, doing pre-clinical research in pulmonary arterial hypertension. She has worked as a pre-clinical and clinical assessor at the State Institute for Drug Control in Slovakia for 8 years, assessing marketing authorizations of drugs. During this time she has also served as a member in the Committee for Orphan Medicinal Products in the European Medicines Agency. Additionally, she has been an alternate in the Committee for Human Medicinal Products and a member of the Scientific Advice Working Party.

                                                                                          Projects by PharmDr. Eva Malikova PhD.

                                                                                          List of projects

                                                                                           

                                                                                          Publications

                                                                                          • preview_image
                                                                                            publikationen-eva-malikova-nov-2024.pdf
                                                                                                                                                              Netzwerk
                                                                                                                                                              • Eunethta
                                                                                                                                                              • Ebm
                                                                                                                                                              • Inahta
                                                                                                                                                              • Dexhelpp
                                                                                                                                                              Shareholder
                                                                                                                                                              • Bmfg
                                                                                                                                                              • Sv
                                                                                                                                                              • Wgfond
                                                                                                                                                              • Noe
                                                                                                                                                              • Ooghfond
                                                                                                                                                              • Ghls
                                                                                                                                                              • Tirol
                                                                                                                                                              • Vorarlberg
                                                                                                                                                              • Kghfond
                                                                                                                                                              • Ghpf
                                                                                                                                                              • Burgef
                                                                                                                                                                        © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                                                                        • Log in